BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9194472)

  • 1. The emerging role of gemcitabine in lung cancer: part I.
    Bunn PA
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-1. PubMed ID: 9194472
    [No Abstract]   [Full Text] [Related]  

  • 2. The emerging role of gemcitabine in lung cancer.
    Bunn PA
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-1. PubMed ID: 9207307
    [No Abstract]   [Full Text] [Related]  

  • 3. Preclinical, pharmacologic, and phase I studies of gemcitabine.
    Storniolo AM; Allerheiligen SR; Pearce HL
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-2-S7-7. PubMed ID: 9194473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine: symptomatic benefit in advanced non-small cell lung cancer.
    Thatcher N; Jayson G; Bradley B; Ranson M; Anderson H
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-6-S8-12. PubMed ID: 9207309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines.
    Hirsch FR; Helfrich B; Franklin WA; Varella-Garcia M; Chan DC; Bunn PA
    Clin Breast Cancer; 2002 May; 3 Suppl 1():12-6. PubMed ID: 12057039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of single-agent gemcitabine in advanced non-small cell lung cancer: a review.
    Hansen HH; Sørensen JB
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-38-S7-41. PubMed ID: 9194478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine for lung cancer.
    Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis--a case report.
    Chen YM; Chen MC; Tsai CM; Perng RP
    Lung Cancer; 2003 Apr; 40(1):99-101. PubMed ID: 12660014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-agent gemcitabine in non-small cell lung cancer: the French experience.
    Le Chevalier T; Gottfried M
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-47-S7-49. PubMed ID: 9194480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on "Gemcitabine: single-agent and combination therapy in non-small cell lung cancer". The Oncologist 1999;4:241-251.
    Edelman MJ
    Oncologist; 1999; 4(3):252-5. PubMed ID: 10394592
    [No Abstract]   [Full Text] [Related]  

  • 11. Genotype-based methods for anticipating gemcitabine-related severe toxicities may lead to false-negative results.
    Mercier C; Evrard A; Ciccolini J
    J Clin Oncol; 2007 Oct; 25(30):4855; author reply 4855-6. PubMed ID: 17947739
    [No Abstract]   [Full Text] [Related]  

  • 12. Is long term gemcitabine useful in small cell lung cancer?
    Dediu M
    Lung Cancer; 2002 May; 36(2):217-8. PubMed ID: 11955659
    [No Abstract]   [Full Text] [Related]  

  • 13. Gemcitabine--a major advance?
    Thomas A; Steward WP
    Ann Oncol; 1998 Dec; 9(12):1265-7. PubMed ID: 9932153
    [No Abstract]   [Full Text] [Related]  

  • 14. Gemcitabine and small cell lung cancer.
    Scarpati MD; Vicidomini G; Santini M
    Lung Cancer; 2001 Nov; 34(2):313-4. PubMed ID: 11679191
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer.
    Manegold C; Drings P; von Pawel J; Ricci S; Dornoff W; van Walree N; ten Bokkel Huinink W; Chemaissani A; Stahel P; Bergman B; Wagenius G; Sederholm C; Mattson K; Liippo K; Kellokumpu-Lehtinen P
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-13-S8-17. PubMed ID: 9207310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II studies of gemcitabine for non-small cell lung cancer in Japan.
    Fukuoka M; Takada M; Yokoyama A; Kurita Y; Niitani H
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-42-S7-46. PubMed ID: 9194479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of new drugs in small cell lung cancer: the activity of gemcitabine.
    Postmus PE; Schramel FM; Smit EF
    Semin Oncol; 1998 Aug; 25(4 Suppl 9):79-82. PubMed ID: 9728590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [First-line non-small-cell lung cancer: role of gemcitabine].
    Barata F
    Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S20-2. PubMed ID: 16273006
    [No Abstract]   [Full Text] [Related]  

  • 19. Gemcitabine (Gemzar) in non-small cell lung cancer.
    Manegold C
    Expert Rev Anticancer Ther; 2004 Jun; 4(3):345-60. PubMed ID: 15161434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer.
    Shepherd FA; Abratt RP; Anderson H; Gatzemeier U; Anglin G; Iglesias J
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-50-S7-55. PubMed ID: 9194481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.